نتائج البحث - "Bruce D. Cheson"

1

Interim Update on the 'Watch' Registry, a Real-World Observational Study Using Clonoseq® to Monitor MRD in Lymphoid Malignancies

المؤلفون: Krish Patel, Jakub Svoboda, Bijal D. Shah, Bruce D. Cheson, Georges Azzi, Kashyap Patel, Andrew J Cowan, Lori Muffly, Heidi Simmons, Mark Schliekelman, Jessica Leonard

المصدر: Blood. 140:5192-5194

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8d6b9ee555369e2071304ffc77aa10e2Test
https://doi.org/10.1182/blood-2022-167669Test

2

Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy

المصدر: Blood. 137:2817-2826

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a3b7821bd11faf72ff6c583cc332886cTest
https://doi.org/10.1182/blood.2020007376Test

3

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

المؤلفون: Bruce D. Cheson, Jessica Vermeulen, Sanjay Deshpande, Ajay K. Gopal, Nathan Fowler, Sriram Balasubramanian, Michael Schaffer, Gilles Salles, Brendan P. Hodkinson, Stephen J. Schuster, Judith Trotman, Steven Sun, Georg Hess

المصدر: Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 61-73 (2022)

مصطلحات موضوعية: Oncology, Cancer Research, Follicular lymphoma, Biochemistry, chemistry.chemical_compound, Genetic signature, Piperidines, Recurrence, Medicine, Exome, Lymphoma, Follicular, Exome sequencing, RC254-282, Research Articles, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hematology, DNA-Binding Proteins, Exact test, Ibrutinib, Refractory Follicular Lymphoma, Clin oncol, Research Article, Genetic Markers, medicine.medical_specialty, Immunology, Antineoplastic Agents, lymphoma, Biology, Germline mutation, Internal medicine, Partial response, Exome Sequencing, Humans, Radiology, Nuclear Medicine and imaging, In patient, business.industry, Adenine, genetic variants, Clinical Cancer Research, biomarkers, Cell Biology, medicine.disease, mutations, FANCA, Mutational analysis, CARD Signaling Adaptor Proteins, chemistry, Guanylate Cyclase, Family medicine, Relapsed refractory, Mutation, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78136d9e3106043c8ecec6b52f9010b8Test
https://pubmed.ncbi.nlm.nih.gov/34791836Test

4

CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET

المؤلفون: Jonathan W. Friedberg, Eric D. Hsi, Brandelyn N. Pitcher, Nancy L. Bartlett, Sin-Ho Jung, Julie E. Chang, John P. Leonard, Heiko Schöder, Lale Kostakoglu, John C. Grecula, Nina D. Wagner-Johnston, Leslie Popplewell, Bruce D. Cheson, Craig H. Moskowitz, David J. Straus, Brad S. Kahl

المصدر: Blood. 132:1013-1021

مصطلحات موضوعية: Adult, Male, BEACOPP, Vincristine, Adolescent, Clinical Trials and Observations, Dacarbazine, medicine.medical_treatment, Immunology, Population, Vinblastine, Procarbazine, Biochemistry, Disease-Free Survival, Bleomycin, 03 medical and health sciences, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Cyclophosphamide, Survival rate, Etoposide, Neoplasm Staging, education.field_of_study, business.industry, Cell Biology, Hematology, Middle Aged, Hodgkin Disease, Survival Rate, ABVD, Doxorubicin, 030220 oncology & carcinogenesis, Prednisone, Female, business, Nuclear medicine, Follow-Up Studies, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::486d4f4ef56776ba2b92341c62ad4421Test
https://doi.org/10.1182/blood-2018-01-827246Test

5

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

المؤلفون: Kanti R. Rai, Hartmut Döhner, Michael J. Keating, Daniel Catovsky, Stephan Stilgenbauer, John C. Byrd, Guillermo Dighiero, John F. Seymour, Barbara Eichhorst, Nicholas Chiorazzi, Bruce D. Cheson, Thomas J. Kipps, Peter Hillmen, Emili Montserrat, Michael Hallek, Susan O'Brien, Tadeusz Robak, Federico Caligaris-Cappio

المصدر: Blood. 131:2745-2760

مصطلحات موضوعية: medicine.medical_specialty, Treatment response, Neoplasm, Residual, Chronic lymphocytic leukemia, Immunology, MEDLINE, Physical examination, Disease, Biochemistry, Immunophenotyping, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, medicine, Humans, Genetic Testing, Disease management (health), Intensive care medicine, Neoplasm Staging, Clinical Trials as Topic, medicine.diagnostic_test, business.industry, Disease Management, Cell Biology, Hematology, Prognosis, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Minimal residual disease, Karyotyping, 030220 oncology & carcinogenesis, Expert opinion, Mutation, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ad14e22958de2a45a8a76f9fedd9a7Test
https://doi.org/10.1182/blood-2017-09-806398Test

6

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

المؤلفون: John P. Leonard, Heiko Schöder, Nancy L. Bartlett, Lale Kostakoglu, Heshan Liu, Michael V. Knopp, Wyndham H. Wilson, Lawrence H. Schwartz, Andrew D. Zelenetz, Jonathan W. Friedberg, Bruce D. Cheson, Eric D. Hsi, Nathan Hall, Howard R. Higley, Nina D. Wagner-Johnston, Brad S. Kahl, Gary J. Kelloff, Mei Yin C. Polley, Jun Zhang

المصدر: Blood

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Fluorine Radioisotopes, Clinical Trials and Observations, Kaplan-Meier Estimate, Biochemistry, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, Etoposide, Aged, 80 and over, education.field_of_study, Lymphoma, Non-Hodgkin, Hazard ratio, Hematology, Middle Aged, Prognosis, Progression-Free Survival, Vincristine, 030220 oncology & carcinogenesis, Female, Lymphoma, Large B-Cell, Diffuse, Rituximab, Adult, medicine.medical_specialty, Immunology, Population, Standardized uptake value, 03 medical and health sciences, Young Adult, Fluorodeoxyglucose F18, Internal medicine, medicine, Humans, Progression-free survival, education, Cyclophosphamide, Aged, Proportional Hazards Models, Proportional hazards model, business.industry, Cell Biology, Confidence interval, Clinical trial, 030104 developmental biology, Positron-Emission Tomography, Prednisone, Radiopharmaceuticals, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e783b179838aa5b8704aa3ed4e70ebaTest
https://pubmed.ncbi.nlm.nih.gov/32556130Test

7

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

المصدر: Blood. 136:46-47

مصطلحات موضوعية: chemistry.chemical_compound, chemistry, Venetoclax, business.industry, Ibrutinib, Immunology, Cancer research, Medicine, Cell Biology, Hematology, Refractory Follicular Lymphoma, business, Biochemistry

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dc438e1c551eb5c4198f46f6e18b3017Test
https://doi.org/10.1182/blood-2020-136219Test

8

The Clinical Relevance of Residual, Persistent and Elongated Abnormal Sized Nodes By Longest Diameter (LDi) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL), Otherwise in a Complete Remission (CR)

المؤلفون: Manish Sharma, Jayant Narang, Surabhi Bajpai, Rudresh Jarecha, Bruce D. Cheson, Christiana Caplan, Gabriele Padrella, Dana Macdonald

المصدر: Blood. 136:34-35

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Chronic lymphocytic leukemia, Immunology, Cell Biology, Hematology, Gold standard (test), medicine.disease, Biochemistry, Minimal residual disease, Lymphoma, Clinical trial, medicine.anatomical_structure, Median follow-up, medicine, Clinical significance, Radiology, business, Lymph node

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c6a9671c489a6f2e9db6ad0174d2ec9aTest
https://doi.org/10.1182/blood-2020-136731Test

9

Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trial

المصدر: Blood. 136:34-35

مصطلحات موضوعية: business.industry, Immunology, Dual inhibitor, Cell Biology, Hematology, Biochemistry, Refractory, Cancer research, Indolent Non-Hodgkin Lymphoma, Medicine, In patient, Casein kinase 1, Once daily, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7f0264f8eeffbe6b7115355844212360Test
https://doi.org/10.1182/blood-2020-134851Test

10

Investigational CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study

المؤلفون: Michael B. Maris, Bruce D. Cheson, Erlene K. Seymour, Kathleen Roberge, Swami P. Iyer, Krish Patel, Yaping Shou, Tina Catalano, Alexander M. Lesokhin, Bob Uger, Gottfried von Keudell, Gloria H. Y. Lin, Penka S. Petrova, Jeff Zonder, Radhakrishnan Ramchandren

المصدر: Blood. 136:46-47

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Follicular lymphoma, Cell Biology, Hematology, Neutropenia, medicine.disease, Biochemistry, Platelet transfusion, Tolerability, Internal medicine, Pharmacodynamics, medicine, Mantle cell lymphoma, Dosing, business, Adverse effect

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::463421af25a6f7f1152a20ab6a9cfd72Test
https://doi.org/10.1182/blood-2020-136607Test

تنقيح النتائج